Cosmos Health (COSM) said Friday that its Cana Laboratories unit agreed to a new 10-year manufacturing contract with Provident Pharmaceuticals.
The contract covers the production of four pharmaceutical products including Miorelique, BE Union F.C. and two variations of Certorun with a total production volume of 800,000 packs per year, according to Cosmos.
Financial terms of the contract were not disclosed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.